TIL Q1 2023 Earnings — Instil Bio, Inc. Revenue & Financial Results | Market Cap Arena

TILInstil Bio, Inc.

$62M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$58M

Net Income

-$57M

EPS (Diluted)

$-8.66

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$43M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$427M

Total Liabilities

$116M

Stockholders' Equity

$311M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$58M	-$54M	-7.7%
Net Income	-$57M	-$54M	-5.5%